15,535 Shares in Alphatec Holdings, Inc. (NASDAQ:ATEC) Purchased by Teacher Retirement System of Texas

Teacher Retirement System of Texas purchased a new position in Alphatec Holdings, Inc. (NASDAQ:ATEC) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 15,535 shares of the medical technology company’s stock, valued at approximately $158,000.

A number of other large investors also recently bought and sold shares of ATEC. Comerica Bank increased its holdings in shares of Alphatec by 66.8% in the fourth quarter. Comerica Bank now owns 3,116 shares of the medical technology company’s stock valued at $29,000 after purchasing an additional 1,248 shares during the last quarter. Quarry LP increased its holdings in shares of Alphatec by 79.2% in the fourth quarter. Quarry LP now owns 5,374 shares of the medical technology company’s stock valued at $49,000 after purchasing an additional 2,375 shares during the last quarter. Lazard Asset Management LLC acquired a new stake in shares of Alphatec in the fourth quarter valued at approximately $76,000. State of Wyoming acquired a new stake in shares of Alphatec in the fourth quarter valued at approximately $86,000. Finally, AlTi Global Inc. acquired a new stake in shares of Alphatec in the fourth quarter valued at approximately $92,000. Institutional investors and hedge funds own 66.35% of the company’s stock.

Insider Buying and Selling at Alphatec

In related news, EVP Craig E. Hunsaker sold 186,122 shares of the company’s stock in a transaction on Wednesday, June 4th. The shares were sold at an average price of $12.34, for a total value of $2,296,745.48. Following the completion of the sale, the executive vice president directly owned 1,463,896 shares in the company, valued at approximately $18,064,476.64. This represents a 11.28% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Karen K. Mcginnis sold 3,963 shares of the business’s stock in a transaction on Wednesday, June 11th. The shares were sold at an average price of $12.11, for a total transaction of $47,991.93. Following the completion of the sale, the director owned 68,709 shares in the company, valued at $832,065.99. This represents a 5.45% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 299,547 shares of company stock valued at $3,698,956. Corporate insiders own 22.80% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently weighed in on ATEC shares. Piper Sandler reiterated an “overweight” rating and issued a $15.00 price objective (up from $13.00) on shares of Alphatec in a research report on Friday, May 2nd. HC Wainwright reiterated a “buy” rating and issued a $20.00 price objective on shares of Alphatec in a research report on Monday, April 14th. Lake Street Capital upgraded Alphatec to a “buy” rating and set a $18.00 price target for the company in a research report on Monday, June 16th. Finally, Needham & Company LLC restated a “buy” rating and set a $16.00 price target on shares of Alphatec in a research report on Friday, May 2nd. Two equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $18.13.

Alphatec Stock Performance

Shares of NASDAQ ATEC opened at $10.49 on Monday. Alphatec Holdings, Inc. has a 1 year low of $4.88 and a 1 year high of $13.14. The firm has a market cap of $1.53 billion, a price-to-earnings ratio of -9.12 and a beta of 1.05. The stock’s 50-day simple moving average is $11.70 and its 200-day simple moving average is $11.09.

Alphatec (NASDAQ:ATEC) last issued its earnings results on Thursday, May 1st. The medical technology company reported ($0.35) EPS for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.23). Alphatec had a negative net margin of 25.77% and a negative return on equity of 1,657.19%. The company had revenue of $169.18 million during the quarter, compared to analyst estimates of $167.57 million. During the same quarter in the previous year, the firm earned ($0.34) earnings per share. The business’s revenue was up 22.2% on a year-over-year basis. As a group, research analysts predict that Alphatec Holdings, Inc. will post -1.08 EPS for the current year.

Alphatec Profile

Alphatec Holdings, Inc, a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems.